jump to content jump to footer

mint Analytics: Real-time data visualization and analysis in clinical trials with imaging endpoints

We talked to PD Dr. Wolfgang G. Kunz, Head of Oncological Imaging and of the Oncological Study Center at the Ludwig Maximilians University Hospital Munich, about his experience with mint Analytics, an extensive add-on of the leading radiological platform mint Lesion™.

Next to the data visualization of multiple trials, PD Dr. Kunz and his team use mint Analytics for quality control of trial site reads and for sharing the current status of trial results with oncological PIs, which provides them with an estimate of what responses can be clinically expected. PD Dr. Kunz also provides an insight into how mint Analytics has the ability to open up new avenues of single and multicentric research projects and how this can benefit other radiologists, oncologists, imaging CROs as well as sponsors.

From PCWG3 to PCWG4: Evolving Standards in Prostate Cancer Clinical Trials

The Prostate Cancer Working Group 4 (PCWG4) updates and extends the recommendations of PCWG3 to reflect a patient-centric approach, the emergence of…

Read more
Centralized Management for Clinical Trial Communications and Workflows

Requests for radiological clinical trial evaluations frequently rely on fragmented methods such as emails, phone calls, and spreadsheets. This…

Read more
mint Lesion usage during a clinical trial read, featuring the TGRM export tool.
Bridging the Gap Between RECIST and Survival: Why the FDA’s Analysis of the g Value is a Game-Changer

For decades, oncology trials have relied on RECIST 1.1 to evaluate drug efficacy. However, these categorical "snapshot" evaluations do not always…

Read more
scroll-top